Replies to post #88920 on Biotech Values

[WID]

OT: SNTA - Does anyone follow SNTA. The company announced that preclinical results presented at the AACR-IASLC (American Academy of Cancer Research.

See link..

http://finance.yahoo.com/news/Synta-Presents-Results-at-bw-3114970089.html?x=0&.v=1

Besides the news on the preclinical result, there is evidence of insiders buying as well. See link below:

http://www.secform4.com/insider-trading/1157601.htm

Please advise!

Best regards,

WID

[DewDiligence]

Re: IDIX report from ‘New BioMedicine’

In February–March 2010, we expect Idenix Pharmaceuticals, Inc. (IDIX), to release the data from the Phase II trial of IDX184, designed for the treatment of hepatitis C virus (HCV) infection.

I think the IDX184 data release is more likely to occur at EASL in April:
http://www2.kenes.com/liver-congress/pages/home.aspx .

JMHO, FWIW